Ambros Therapeutics, headquartered in Irvine, California, is a clinical-stage biotechnology company focused on the development of innovative and transformative medicines for diseases with a high unmet medical need.  Our lead investigational program targets complex regional pain syndrome type 1 (CRPS-1), a devastating rare disease that causes severe, unrelenting and frequently lasting pain following trauma to the bone or an injury.  Patients may experience significant functional loss, sleep disturbance, and meaningful diminished quality of life and independence. The Phase 3 pivotal trial (CRPS-RISE) represents a first-in-class approach to addressing a disease with no FDA-approved therapies. 

For more information, please visit https://clinicaltrials.gov/study/NCT07210515

Ambros Therapeutics

Jay Hagan

This department provides expert advice and solutions across various business functions to enhance organizational performance.

Consulting Services

This department oversees the management and execution of clinical programs and related operations.

Clinical Operations

This department focuses on overseeing organizational policies and ensuring compliance with regulatory standards.

Governance and Oversight

This department facilitates communication and collaboration in scientific matters across various functions.

Scientific Affairs

This department focuses on strategic partnerships, mergers, acquisitions, and overall corporate growth initiatives.

Corporate Development

This department oversees and supports the strategic and operational activities related to medical information, research, and regulatory compliance.

Ambros Therapeutics

Org chart

Teams

Consulting Services

Clinical Operations

Governance and Oversight

Scientific Affairs

Corporate Development

Medical Affairs

Offices

Ambros Therapeutics

Org chart

Teams

Consulting Services

Clinical Operations

Governance and Oversight

Scientific Affairs

Corporate Development

Medical Affairs

Offices

Related companies